Search alternatives:
ppm decrease » _ decrease (Expand Search), pa decreased (Expand Search), 026 decrease (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 mg » 5 mm (Expand Search)
e nn » e non (Expand Search), _ nn (Expand Search), k nn (Expand Search)
Showing 141 - 160 results of 20,338 for search '(( 50 ((ppm decrease) OR (a decrease)) ) OR ((( 5 mg decrease ) OR ( e nn decrease ))))', query time: 0.54s Refine Results
  1. 141
    The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability.

    The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

    Published 2025
    Save to List
    Saved in:
  2. 142
    Fig 2 -

    Fig 2 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 143
    Fig 3 -

    Fig 3 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 144
    Fig 4 -

    Fig 4 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 145
    Fig 1 -

    Fig 1 - by Nida Mansoora (11648641)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 146
    Effect of different treatments on ionic contents like sodium, calcium, potassium, phosphorous and soluble proteins constituents of two wheat genotypes (Markaz 19 and Ujala 16) after 35 d of the growth period in pots.

    Effect of different treatments on ionic contents like sodium, calcium, potassium, phosphorous and soluble proteins constituents of two wheat genotypes (Markaz 19 and Ujala 16) afte... by Nida Mansoora (11648641)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 147
    Participants with virologic suppression or failure at week 24.

    Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 148
    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART.

    Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 149
    Consolidated Standards of Reporting Trials flow diagram for participants in the trial.

    Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 150
    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model.

    Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 151
    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24.

    Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 152
    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 153
    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24.

    Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 154
    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24.

    Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 155
    Fig 5 -

    Fig 5 - by Saeed El-Ashram (710370)

    Published 2021
    Save to List
    Saved in:
  16. 156
    Fig 5 -

    Fig 5 - by Wenping Dong (3854437)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 157
    The primers related to FAM50A.

    The primers related to FAM50A. by Longhai Li (4052044)

    Published 2025
    “…Knockdown of FAM50A decreased cell proliferation ability, the proportion of EdU positive cells, and the number of CRC cell colonies, whereas overexpressing FAM50A promoted proliferative phenotypes. …”
    Save to List
    Saved in:
  18. 158
    rt-PA-induced lysis of different clot sizes.

    rt-PA-induced lysis of different clot sizes. by Jan Víteček (11434774)

    Published 2024
    Save to List
    Saved in:
  19. 159
    Complete data.

    Complete data. by Jan Víteček (11434774)

    Published 2024
    “…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. …”
    Save to List
    Saved in:
  20. 160
    Fig 4 -

    Fig 4 - by Jan Víteček (11434774)

    Published 2024
    “…The rt-PA became increasingly less efficient for clots larger than 50 μl at a clinically relevant concentration of 1.3 mg/l. …”
    Save to List
    Saved in:

Search Tools: